KalVista Pharmaceuticals, Inc.
Board Member
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Earlier roles on record: Board Member at KalVista Pharmaceuticals, Inc. until October 13, 2022. KalVista Pharmaceuticals, Inc. reported in an 8-K filed October 17, 2022 that Martin Edwards resigned as Chairman of the Board of Directors, effective October 13, 2022.
“On October 13, 2022, Martin Edwards, M.D., announced his resignation from his position as the Chairman of the Board of Directors (the "Board") and as a Class III director, member of the Compensation Committee of the Board (the "Compensation Committee") and member of the Nominating and Corporate Governance Committee of the Board (the "Nominating and Corporate Governance Committee") of KalVista Pharmaceuticals, Inc. (the "Company"), effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
KalVista Pharmaceuticals, Inc.
Board Member
Proxy statement
Start not stated–2022-10-13
Recorded roles and call appearances connecting this person to public companies.
KalVista Pharmaceuticals, Inc.
Board Member
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.